Markou K - Search Results

1

Hyperbaric oxygen as salvage treatment for idiopathic sudden sensorineural hearing loss.

Psillas G, Ouzounidou S, Stefanidou S, Kotsiou M, Giaglis GD, Vital I, Tsalighopoulos M, Markou K. Psillas G, et al. Among authors: markou k. B-ENT. 2015;11(1):39-44. B-ENT. 2015. PMID: 26513946

2

Transiently evoked otoacoustic emissions as a prognostic indicator in idiopathic sudden hearing loss.

Lalaki P, Markou K, Tsalighopoulos MG, Daniilidis I. Lalaki P, et al. Among authors: markou k. Scand Audiol Suppl. 2001;(52):141-5. doi: 10.1080/010503901300007344. Scand Audiol Suppl. 2001. PMID: 11318448

3

Factors influencing tumour relapse after total laryngectomy.

Nikolaou A, Markou K, Petridis D, Vlachtsis K, Nalbantian M, Daniilidis L. Nikolaou A, et al. Among authors: markou k. B-ENT. 2005;1(1):1-10. B-ENT. 2005. PMID: 15999669

4

An alternative manoeuvre for posterior canal BPPV treatment.

Vital V, Psillas G, Printza A, Vital I, Triaridis S, Konstantinidis I, Markou K, Tsalighopoulos M. Vital V, et al. Among authors: markou k. B-ENT. 2010;6(1):9-13. B-ENT. 2010. PMID: 20420074

5

Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial.

Tsounis M, Psillas G, Tsalighopoulos M, Vital V, Maroudias N, Markou K. Tsounis M, et al. Among authors: markou k. Eur Arch Otorhinolaryngol. 2018 Jan;275(1):103-110. doi: 10.1007/s00405-017-4803-5. Epub 2017 Nov 22. Eur Arch Otorhinolaryngol. 2018. PMID: 29168028 Clinical Trial.

6

Benign paroxysmal positional vertigo in the first acute attack of Ménière's disease.

Psillas G, Triaridis S, Markou K, Tsalighopoulos M, Vital V. Psillas G, et al. Among authors: markou k. B-ENT. 2011;7(2):131-5. B-ENT. 2011. PMID: 21838099

7

A Trauma Patient in the Otology Clinic: A Vestibular Fracture in the Acute Setting.

Stavrakas M, Tsetsos N, Psillas G, Markou K. Stavrakas M, et al. Among authors: markou k. Ear Nose Throat J. 2021 Feb 22:145561321993935. doi: 10.1177/0145561321993935. Online ahead of print. Ear Nose Throat J. 2021. PMID: 33617295 No abstract available.

8

How often is total laryngectomy necessary for the treatment of T1 failures after radiotherapy or cordectomy?

Markou K, Nikolaou A, Nalbadian M, Petridis D, Nicolaidis V, Daniilidis I. Markou K, et al. Eur Arch Otorhinolaryngol. 2002 Jan;259(1):4-10. doi: 10.1007/pl00007527. Eur Arch Otorhinolaryngol. 2002. PMID: 11954925

9

Incidence and predisposing factors of pharyngocutaneous fistula formation after total laryngectomy. Is there a relationship with tumor recurrence?

Markou KD, Vlachtsis KC, Nikolaou AC, Petridis DG, Kouloulas AI, Daniilidis IC. Markou KD, et al. Eur Arch Otorhinolaryngol. 2004 Feb;261(2):61-7. doi: 10.1007/s00405-003-0643-6. Epub 2003 Jul 10. Eur Arch Otorhinolaryngol. 2004. PMID: 12856129

10

Clinical and molecular prognostic factors in operable laryngeal cancer.

Vlachtsis K, Nikolaou A, Markou K, Fountzilas G, Daniilidis I. Vlachtsis K, et al. Among authors: markou k. Eur Arch Otorhinolaryngol. 2005 Nov;262(11):890-8. doi: 10.1007/s00405-005-0916-3. Epub 2005 Mar 1. Eur Arch Otorhinolaryngol. 2005. PMID: 15739081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results